NEWARK, Del., April 8, 2026 — According to the latest analysis by Future Market Insights, the global keloid treatment market is undergoing a structural transformation, driven by the shift from cosmetic scar management to clinical fibrotic disease treatment. Valued at USD 4,292.2 million in 2026, the market is projected to reach USD 6,202.8 million by 2036, expanding at a...